DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for Australia Patent: 2622301
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Australia Patent: AU2622301
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2019-11-05 | filgrastim | Amgen | NEUPOGEN |
Start Trial | 2019-11-05 | filgrastim | Amgen | NEUPOGEN |
Start Trial | 2019-11-05 | filgrastim | Amgen | NEUPOGEN |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |